Full Text View
Tabular View
No Study Results Posted
Related Studies
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
This study has suspended participant recruitment.
( Study drug not available at this time )
Study NCT01267643   Information provided by The Cleveland Clinic

First Received on December 20, 2010.   Last Updated on February 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Aplastic Anemia
Additional conditions recognized in this trial
Anemia
Anemia, Aplastic
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Interventions listed in this trial
Alefacept
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The Cleveland Clinic
Astellas Pharma US, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services